tldrdailynews.com logo

Novo Nordisk Ends Partnership with Hims & Hers Over Wegovy Concerns

1 min read
Source: Reuters
Novo Nordisk Ends Partnership with Hims & Hers Over Wegovy Concerns
Photo: Reuters
TL;DR Summary

Novo Nordisk has ended its partnership with Hims & Hers over the distribution of Wegovy, a weight loss drug, amid legal and regulatory issues, leading to a decline in stock prices for both companies.

Topics:business#business#collaboration#hims-and-hers#novo-nordisk#wegovy#weight-loss-drugs
Share this article
  1. Novo Nordisk ends Hims & Hers collaboration over Wegovy weight loss drug  Reuters
  2. Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%  CNBC
  3. Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership  Barron's
  4. Novo Exits Hims & Hers Partnership, Citing Compounding Concerns  Bloomberg.com
  5. Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.  MarketWatch

Reading Insights

Total Reads

0

Unique Readers

13

Time Saved

2 min

vs 2 min read

Condensed

91%

373 → 34 words

Want the full story? Read the original article

Read on Reuters